BNA Publications

– Evolution of the Antidepressant Prescribing in Alzheimer’s Disease and Related Disorders Between 2010 and 2014 : Results from the French National Database on Alzheimer’s Disease (BNA). Journal of Alzheimer’s Disease 53 (2016) 1365–1373

– Progression of mild cognitive impairment to dementia due to AD in clinical settings. Neurology® 2015;85:1–8

– The Mini Mental State Examination at the Time of Alzheimer’s Disease and Related Disorders Diagnosis, According to Age, Education, Gender and Place of Residence: A Cross-Sectional Study among the French National Alzheimer Database.  PLoS One. 2014 Aug 5;9(8):e103630.

– Who Needs Cerebrospinal Biomarkers ? A National Survey in Clinical Practice. J Alzheimers Dis. Feb 20 2014.

 – The French National Alzheimer Database: A Fast Growing Database for Researchers and Clinicians.  Dement Geriatr Cogn Disord. 2014 Jul 2;38(5-6):271-280.

 – Mild cognitive impairment and anti-Alzheimer disease medications: A cross sectional study of the French National Alzheimer Databank (BNA).  J Alzheimers Dis. 2014;38(3):541-9.

 – Use of drug treatments for Alzheimer’s disease in France: a study on a national level based on the National Alzheimer’s Data Bank (Banque Nationale Alzheimer). Pharmacoepidemiol Drug Saf. 2012 Sep;21(9):1005-12.

 – The 2008-2012 French Alzheimer plan: description of the national Alzheimer information system.  J Alzheimers Dis. 2012;29(4):891-902.


Click on the link to access to a full BNA description / cliquer sur le lien pour accéder à la description complete de la BNA (en anglais)

Click on the link to access to the PLOS ONE article / cliquer sur le lien pour accéder à l’article de PLOS ONE